EC Clinical and Medical Case Reports

Cervical leiomyosarcoma is a rare malignant tumor that develops from the smooth muscle cells of the lining of the cervix. It usually forms in middle-aged women and can cause symptoms such as abnormal vaginal bleeding, pelvic pain, and an increase in the size of the uterus. We report a case of cervically delivered leiomyosarcoma initially diagnosed by anatomic pathology examination of a biopsy of the process delivered through the cervix carried out in an outpatient setting on a 70-year-old woman. This is a special case as the diagnosis is often difficult to make because it can be confused with other forms of cervical cancer or uterine fibroids. Imaging tests such as ultrasound and CT scan can be used to assess the size and the location of the tumor, while a biopsy can confirm the diagnosis. Treatment for leiomyosarcoma of the cervix may include surgery to remove the tumor and, in some cases, the uterus. Radiation therapy and chemotherapy may also be used to reduce the risk of cancer recurring or spreading.

 Keywords: Leiomyosarcoma; Metrorrhagia; Diagnosis and Surgical Management

1. Salazar OM., et al. “Uterine sarcomas: natural history, treatment and prognosis”. Cancer3 (1978): 1152-1160.
2. Livi L., et al. “Uterine sarcoma: twenty-seven years of experience”. International Journal of Radiation Oncology, Biology, Physics 5 (2003): 1366-1373.
3. Acharya S., et al. “Rare uterine cancers”. Lancet Oncology12 (2005): 961-971.
4. Livi L., et al. “Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998”. Clinical Oncology (Royal College of Radiologists) 4 (2004): 261-268.
5. Van Dinh T and Woodruff JD. “Leiomyosarcoma of the uterus”. American Journal of Obstetrics and Gynecology 7 (1982): 817-823.
6. Schwartz LB., et al. “Leiomyosarcomas: clinical presentation”. American Journal of Obstetrics and Gynecology1 (1993): 180-183.
7. Leibsohn S., et al. “Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas”. American Journal of Obstetrics and Gynecology4 (1990): 968-974. discussion 974-976.
8. Nordal RR and Thoresen SO. “Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality”. European Journal of Cancer 6 (1997): 907-911.
9. Socolov RV., et al. “La malignité du sarcome utérin, par comparaison avec les léiomyomes suspects: étude anatomo-clinique sur 16 cas”. Revue Française de Gynécologie et D'obstétrique 10 (1992): 457-460.
10. Hata K., et al. “Sonographics findings of uterine leiomyosarcoma”. Gynecologic and Obstetric Investigation 4 (1990): 242-245.
11. Goff BA., et al. “Uterine leiomyosarcoma and endometrial stroma sarcoma: lymph node metastases and sites of recurrence”. Gynecologic Oncology 1 (1993): 105-109.
12. Gerst PH., et al. “Metastatic leiomyosarcoma of the uterus: an usual presentation of a case with late endobronchial and small bowel metastases”. Gynecologic Oncology 2 (1993): 271-275.